Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial

Robert K. Dyer, Martin A. Weinstock, Tobias S.D. Cohen, Amilcar E. Rizzo, Stephen F. Bingham, Martin A. Weinstock, Kimberly Marcolivio, Martin Wainstock, Stephen Binghem, John DiGiovanna, Russell Hall, Mark Naylor, J. Richard Taylor, Julia Vertrees, Clifton White, Russell Hell, Deborah Hannah, David Eilers, Tehming Liang, Nadia SaklaAnn Kreuger, Gary Cole, Edward Jeffes, Terri Labrador, J. Richard Taylor, Robert Kirsner, Jonette E. Kerri, Anna G. Falabella, Margarita Givens, Mark Neylor, Mary Beth Benson, Lisa Perry, James Kalivas, Catherine Yanni, Selma Targovnik, Janet Austin, Susan Collier, Joseph F. Collins, Stephen Bingam, Beverly Calvert, Philip Connor, Colleen Crigler, Dawn Davis, Pat Grubb, Judy Kelly, Gail Kirk, Karen Lawson, Linda Linzy, Lorrine Palmer, Maxine Rhoads, Mike Sather, Erica Copeland, Carol Fye, William Gagne, Patricia Grimes De Naranjo, Chad Messick, Julia Vertreas, Michael Piepkorn, Clifton Whita, Robert Lew, Irwin Braverman, Bernard Cole, Richard Kalish, David McLean, Bruce Thiers

Research output: Contribution to journalArticle

21 Scopus citations

Abstract

Basal cell carcinoma (BCC) is the most common cancer in the United States today, and patients who have had one are likely to have multiple carcinomas over time. Predictors of new BCCs on the face and ears among those at very high risk have not been studied in detail. We sought to do so prospectively in the context of a 6-year trial. We found that the number of BCCs in the prior 5 years was the most important predictor. Age, sun sensitivity, occupational sun exposure before the age of 30 years (but not afterward), lower educational level, history of eczema, the use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, and more sunscreen use in the week, but not the 6 months, before enrollment were also independent predictors, but sunburns, baseline sun exposure, and other sun-protective measures, other skin cancers, and actinic keratoses were not. None of the eczema patients had a history of topical calcineurin use. The cumulative risk of BCC was 55% at 5 years. These findings document the key risk factors in this very high-risk population, suggesting that the history of eczema may increase the risk in those at high risk and that early sun exposure is important even in this group, and underscoring the need for chemopreventive strategies.

Original languageEnglish (US)
Pages (from-to)2544-2551
Number of pages8
JournalJournal of Investigative Dermatology
Volume132
Issue number11
DOIs
StatePublished - Nov 2012
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Dermatology
  • Cell Biology

Fingerprint Dive into the research topics of 'Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial'. Together they form a unique fingerprint.

  • Cite this

    Dyer, R. K., Weinstock, M. A., Cohen, T. S. D., Rizzo, A. E., Bingham, S. F., Weinstock, M. A., Marcolivio, K., Wainstock, M., Binghem, S., DiGiovanna, J., Hall, R., Naylor, M., Taylor, J. R., Vertrees, J., White, C., Hell, R., Hannah, D., Eilers, D., Liang, T., ... Thiers, B. (2012). Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial. Journal of Investigative Dermatology, 132(11), 2544-2551. https://doi.org/10.1038/jid.2012.227